Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
25.21
0.10 (0.40%)
At close: Aug 15, 2025, 2:46 PM
Pfizer Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 29, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Dec 31, 2021 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 |
Net Income | 2.93B | 2.97B | 411M | 4.48B | 31M | 3.13B | -3.34B | -2.39B | 2.33B | 5.54B | 5B | 8.64B | 9.87B | 7.88B | 3.85B | 8.17B | 5.57B | 4.88B |
Depreciation & Amortization | 1.63B | 1.62B | 1.79B | 1.75B | 1.73B | 1.74B | 1.67B | 1.56B | 1.57B | 1.49B | 1.52B | 1.18B | 1.18B | 1.19B | 1.28B | 1.36B | 1.33B | 1.23B |
Stock-Based Compensation | 203M | 170M | 177M | 274M | 206M | 220M | 121M | 151M | 148M | 105M | 364M | 135M | 287M | 86M | 495M | 293M | 221M | 172M |
Other Working Capital | 1.92B | -1.92B | 2.93B | 879M | -3.54B | -3.34B | 8.45B | -1.2B | -3.92B | -5.51B | 1.1B | -4.11B | -2.77B | -730M | 5.68B | 6.76B | 5.38B | -1.33B |
Other Non-Cash Items | -6.99B | 156M | 1.81B | -193M | 569M | -217M | 201M | 5.45B | -470M | 184M | -1.09B | 59M | 742M | 440M | -1.1B | -2.01B | -1.05B | -609M |
Deferred Income Tax | -272M | -663M | -396M | -482M | -783M | -441M | -1.86B | -113M | -873M | -598M | -365M | 62M | -1.14B | -2.32B | -591M | -3.75B | -152M | 199M |
Change in Working Capital | 1.92B | -1.92B | 2.93B | 879M | -3.54B | -3.34B | 8.45B | -1.2B | -3.92B | -5.51B | 3.15B | -4.11B | -2.77B | -730M | 1.99B | 6.76B | 5.38B | -1.33B |
Operating Cash Flow | -582M | 2.33B | 6.72B | 6.71B | -1.78B | 1.09B | 5.24B | 3.46B | -1.21B | 1.21B | 8.58B | 5.97B | 8.17B | 6.54B | 5.91B | 10.83B | 11.3B | 4.54B |
Capital Expenditures | -618M | -564M | -917M | -651M | -637M | -704M | -1.04B | -810M | -914M | -1.14B | -1B | -841M | -751M | -643M | -993M | -624M | -540M | -554M |
Cash Acquisitions | -6.31B | 6.31B | 3.55B | n/a | n/a | 3.49B | -43.41B | -2M | -25M | -1M | -16.77B | n/a | n/a | -6.22B | -12M | n/a | n/a | n/a |
Purchase of Investments | -2.03B | -6.81B | -6.28B | -2.67B | 657M | -2.02B | -874M | -9.21B | -14.38B | -6.72B | 3.42B | -18.79B | -17.39B | -9.43B | -13.32B | -17.71B | -9.51B | -7.08B |
Sales Maturities Of Investments | 12.92B | 4.04B | 2.01B | 1.26B | 4.6B | 963M | 34.31B | 10.56B | -9.64B | 11.19B | 9.93B | 15.16B | 6.9B | 16.88B | 11.68B | 8.55B | 2.15B | 5.72B |
Other Investing Acitivies | -9M | 299M | 12M | 6M | -19M | 1M | 15M | 350M | -524M | -18M | 9M | 3.85B | -77M | -13M | 64M | -298M | -235M | 163M |
Investing Cash Flow | 3.95B | 3.27B | -1.62B | -2.06B | 4.6B | 1.73B | -11B | 888M | -25.48B | 3.31B | -4.41B | -627M | -11.31B | 567M | -2.59B | -10.08B | -8.14B | -1.75B |
Debt Repayment | -731M | -2.43B | -2.72B | -2.25B | -16M | -2.17B | 7.78B | -1.43B | 29.63B | -32M | -2.78B | -3.52B | 4.61B | -1.83B | -1.36B | 759M | -474M | -25M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2B | n/a | n/a | n/a | n/a |
Dividend Paid | -2.44B | -2.44B | -2.38B | -2.38B | -2.38B | -2.37B | -2.31B | -2.31B | -2.31B | -2.3B | -2.25B | -2.25B | -2.24B | -2.25B | -2.19B | -2.19B | -2.18B | -2.17B |
Other Financial Acitivies | -21M | -356M | -14M | -6M | -63M | -386M | -18M | -37M | -141M | -436M | 7M | 5M | 153M | -500M | 201M | 325M | 100M | -610M |
Financial Cash Flow | -3.2B | -5.23B | -5.11B | -4.64B | -2.46B | -4.93B | 5.44B | -3.78B | 27.17B | -2.77B | -5.01B | -5.76B | 2.52B | -6.58B | -3.35B | -1.1B | -2.56B | -2.81B |
Net Cash Flow | 213M | 374M | -45M | 40M | 343M | -2.14B | -295M | 535M | 476M | 1.75B | -870M | -486M | -690M | 530M | -22M | -384M | 609M | -16M |
Free Cash Flow | -1.2B | 1.77B | 5.8B | 6.06B | -2.42B | 386M | 4.2B | 2.65B | -2.12B | 74M | 7.58B | 5.13B | 7.42B | 5.9B | 4.92B | 10.21B | 10.76B | 3.98B |